FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Vilvet Pharmaceuticals Vilamit Mb Recall

VILAMIT MB (118 mg methenamine, 36 mg phenyl salicylate, 40

Vilvet Pharmaceuticals Inc. · Chester Springs, PA

Risk level
Class II
Reported by FDA
Aug 12, 2020
Recall ID
D-1487-2020
Check your lot numberHow we source this data

Summary

Vilvet Pharmaceuticals recalled Vilamit Mb starting Jul 24, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1487-2020 on Aug 12, 2020. Reason: cGMP deviations. Status: Terminated.

Why it was recalled

cGMP deviations

Product description

VILAMIT MB (118 mg methenamine, 36 mg phenyl salicylate, 40.8 mg sodium phosphate monobasic, 10.0 mg methylene blue and 0.12 mg hyoscyamine sulfate), Rx Only, 100 Capsules per Bottle, Manufactured for: Vilvet Pharmaceuticals Inc., Chester Springs, PA 18425, NDC 71186-002-35.

Lot numbers, UPCs & expiration codes

LOT M824H18-1 EXP 08/20 LOT M824J18-1 EXP 09/20 LOT M824L18-1 EXP 11/20 LOT M824A19-1 EXP 01/21 LOT M824C19-1 EXP 03/21 LOT M824G19-1 EXP 07/21

Where it was sold

Nationwide within the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1487-2020
Classification
Class II
Status
Terminated
Recall initiated
Jul 24, 2020
FDA report date
Aug 12, 2020
Quantity
11,640 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Vilvet Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-1487-2020, exactly as published.

Show all FDA fields
City
Chester Springs
State
PA
Status
Terminated
Country
United States
Event ID
86069
Address
1208 Kimberton Rd Ste 101
Code information
LOT M824H18-1 EXP 08/20 LOT M824J18-1 EXP 09/20 LOT M824L18-1 EXP 11/20 LOT M824A19-1 EXP 01/21 LOT M824C19-1 EXP 03/21 LOT M824G19-1 EXP 07/21
Postal code
19425-1437
Report date
Aug 12, 2020
Product type
Drugs
Recall number
D-1487-2020
Classification
Class II
Recalling firm
Vilvet Pharmaceuticals Inc.
Product quantity
11,640 bottles
Termination date
Jan 21, 2022
Reason for recall
cGMP deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
VILAMIT MB (118 mg methenamine, 36 mg phenyl salicylate, 40.8 mg sodium phosphate monobasic, 10.0 mg methylene blue and 0.12 mg hyoscyamine sulfate), Rx Only, 100 Capsules per Bottle, Manufactured for: Vilvet Pharmaceuticals Inc., Chester Springs, PA 18425, NDC 71186-002-35.
Distribution pattern
Nationwide within the US
Recall initiation date
Jul 24, 2020
Initial firm notification
Letter
Center classification date
Aug 6, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1487-2020, published Aug 12, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls